First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
about
Drug treatment of pulmonary hypertension in childrenLong-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settingsThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesEffect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension.Review of bosentan in the management of pulmonary arterial hypertensionSildenafil in pediatric pulmonary arterial hypertension.Advances in therapies for pediatric pulmonary arterial hypertension.The management of acute pulmonary arterial hypertension.Combination therapy in pulmonary arterial hypertension: do we have the right strategy?Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy.Pulmonary hypertension and breathlessness: is it a combination we can ignore?Current and advancing treatments for pulmonary arterial hypertension in childhood.Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results.Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study.Substrate-specific pharmacokinetic interaction between endothelin receptor antagonists and phosphodiesterase-5 inhibitors--assembling the clues.Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre.Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects.
P2860
Q26996078-B3C40E86-3769-4A8F-AFB6-24CD13E6CF04Q34254924-AE63C5C1-E0E4-4B74-9BF8-D8CB14CC3A21Q35156618-4F2E9EF9-8450-4F2B-A564-EC2475D73966Q36128838-B34F8442-6C09-4A00-8E8C-C3C7306035FBQ36596818-4D164747-9B92-4CBD-B32A-461469FB6753Q37091197-4A8FCE4B-9F49-4EEA-A141-2AD712794B76Q37755020-50FD0C70-13E4-446A-B1CF-4E6C92D19E66Q37766261-C604823F-7569-4371-8729-693C1EEBF86CQ37867668-A5C75EB3-C930-48F9-A040-1AE4677FDA74Q38043446-A85E825F-550D-47BD-81D8-D4A44EFE4388Q38175197-6ECA6A3D-4AEC-4CEF-875D-65A9A3B925ECQ38232339-059AA993-B0F1-4DB3-B89F-40FCA6C9A4F2Q38368957-1FF30CDC-7F69-4D15-B320-E4BB2E6416ABQ41625552-CA2208CC-203B-417A-8805-2EB9B3DC51B8Q41852030-C45AC595-1EAA-4583-A725-428AAA8677B2Q42633722-0C3D7BCE-8021-4B70-834D-4ADABA683319Q43132024-2B84C174-381F-4766-A696-8B313C696831Q43680261-3437C2A0-AD58-4EF9-BDBF-BE2BAD612356Q46729796-2E361A3D-C92A-460F-BFEF-8C16CE0DBF37
P2860
First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
First experience with an oral ...... lmonary arterial hypertension.
@en
First experience with an oral ...... lmonary arterial hypertension.
@nl
type
label
First experience with an oral ...... lmonary arterial hypertension.
@en
First experience with an oral ...... lmonary arterial hypertension.
@nl
prefLabel
First experience with an oral ...... lmonary arterial hypertension.
@en
First experience with an oral ...... lmonary arterial hypertension.
@nl
P2093
P2860
P1476
First experience with an oral ...... lmonary arterial hypertension.
@en
P2093
E G Mühler
F Uhlemann
I Schulze-Neick
P2860
P356
10.1111/J.1365-2362.2006.01692.X
P478
36 Suppl 3
P577
2006-09-01T00:00:00Z